Zephyrnet-logo

Een SPAC I roept een vergadering bijeen voor stemming over de NewGenIvf-deal | SPAC-feed

Datum:

A SPAC I in a proxy filing set a March 1 date for shareholders to vote on a proposed merger with fertility company NewGenIvf.

De doel is a full-service fertility services provider in Azië. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan.

Announced a year ago today, the transaction values NewGen at an implied enterprise value of approximately $50 million.

A SPAC I initially raised $60 million in February 2022 to target the technology and e-commerce industries with a focus in Asia and on companies with an enterprise value of between $250 million and $600 million, excluding any company in China. Lees meer.


Bron: A SPAC I Calls Meeting for Vote on NewGenIvf Deal

spot_img

Laatste intelligentie

spot_img